Trial intelligence / Profile preview

Local recombinant factor VIIa for severe postpartum hemorrhage

2013-005036-20Phase 2Completed

Sponsor
Stellaris Pharmaceuticals
Start
Feb 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of coagulation factor VIIa in postpartum hemorrhage (PPH) and placenta previa, sponsored by Stellaris Pharmaceuticals. Started Feb 2014; status: completed.

02

Drugs

coagulation factor VIIa
03

Conditions

postpartum hemorrhage (PPH)placenta previa

Beyond the preview

Go deeper on 2013-005036-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005036-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call